| Primary |
| Liver Transplant |
30.1% |
| Renal Transplant |
24.0% |
| Heart Transplant |
18.7% |
| Immunosuppression |
4.1% |
| Transplant |
3.7% |
| Prophylaxis |
3.3% |
| Lung Transplant |
2.8% |
| Sinusitis |
2.4% |
| Hypertension |
2.0% |
| Organ Transplant |
2.0% |
| Hypertriglyceridaemia |
1.6% |
| Diabetes Mellitus |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Prophylaxis Against Transplant Rejection |
0.8% |
| Renal Failure Chronic |
0.8% |
| Anxiety |
0.4% |
| Complications Of Transplanted Lung |
0.4% |
| Coronary Artery Disease |
0.4% |
| Depression |
0.4% |
| Gout |
0.4% |
|
| Renal Failure Chronic |
7.8% |
| Renal Haematoma |
7.8% |
| Cardiac Arrest |
5.9% |
| Concomitant Disease Progression |
5.9% |
| Death |
5.9% |
| Incisional Hernia |
5.9% |
| Mouth Ulceration |
5.9% |
| Pancytopenia |
5.9% |
| Pneumonia |
5.9% |
| Abdominal Pain |
3.9% |
| Abortion Spontaneous |
3.9% |
| Anaemia |
3.9% |
| Cough |
3.9% |
| Cytomegalovirus Infection |
3.9% |
| Glomerulonephritis Membranoproliferative |
3.9% |
| Liver Function Test Abnormal |
3.9% |
| Liver Transplant Rejection |
3.9% |
| Nausea |
3.9% |
| Nephrotic Syndrome |
3.9% |
| Pyrexia |
3.9% |
|
| Secondary |
| Heart Transplant |
21.6% |
| Renal Transplant |
19.1% |
| Liver Transplant |
13.6% |
| Immunosuppression |
11.1% |
| Lung Transplant |
8.6% |
| Transplant |
7.4% |
| Prophylaxis |
3.7% |
| Hypertension |
3.1% |
| Diabetes Mellitus |
2.5% |
| Hypercholesterolaemia |
2.5% |
| Oesophagitis |
1.9% |
| Depression |
1.2% |
| Hypertriglyceridaemia |
1.2% |
| Hypothyroidism |
1.2% |
| Neuropathy Peripheral |
1.2% |
|
| Concomitant Disease Progression |
18.2% |
| Superinfection |
13.6% |
| Pneumonia |
9.1% |
| Abdominal Pain |
4.5% |
| Arteriovenous Malformation |
4.5% |
| Gallbladder Disorder |
4.5% |
| Oropharyngeal Pain |
4.5% |
| Phlebitis |
4.5% |
| Renal Failure Acute |
4.5% |
| Renal Haematoma |
4.5% |
| Upper Gastrointestinal Haemorrhage |
4.5% |
| Wound Dehiscence |
4.5% |
| Anaemia |
2.3% |
| Ataxia |
2.3% |
| Atrial Fibrillation |
2.3% |
| Bronchial Haemorrhage |
2.3% |
| Confusional State |
2.3% |
| Coronary Artery Bypass |
2.3% |
| Cough |
2.3% |
| Cytomegalovirus Viraemia |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.3% |
| Heart Transplant |
16.7% |
| Prostate Cancer |
16.7% |
| Bronchopulmonary Aspergillosis |
8.3% |
| Diabetes Mellitus |
8.3% |
| Supplementation Therapy |
8.3% |
| Prophylaxis Against Transplant Rejection |
4.2% |
| Renal Transplant |
4.2% |
|
| Temporal Arteritis |
50.0% |
| Death |
25.0% |
| Tularaemia |
25.0% |
|
| Interacting |
| Cytomegalovirus Infection |
50.0% |
| Heart Transplant |
50.0% |
|
| Erythropoiesis Abnormal |
100.0% |
|
